article thumbnail

Effect of low-dose rivaroxaban on bleeding events in low-weight patients with nonvalvular atrial fibrillation: a retrospective propensity score-matched cohort study

Frontiers in Cardiovascular Medicine

The patients were followed up for an average of 15 months by outpatient examination, telephone follow-up, or medical record inquiry of readmission patients. The patients were divided into standard-dose group (15–20 mg) and low-dose group (10–15 mg).

article thumbnail

Outpatient worsening of heart failure and mortality in transthyretin amyloid cardiomyopathy

European Journal of Heart Failure

WHF characterized by outpatient intensification of oral loop diuretics is common yet its prognostic implications for ATTR-CM patients relative to other WHF events remains unclear. We assessed how WHF characterized by outpatient diuretic intensification (ODI) relates to mortality in this population. per 100 person-years; 95% CI 17.750.3)

article thumbnail

Orally Inhaled Flecainide for Conversion of AF to Sinus Rhythm

American College of Cardiology

What is the efficacy and safety of a single dose of 120 mg of flecainide acetate oral inhalation solution (FlecIH) administered in a monitored outpatient setting for the conversion of recent-onset atrial fibrillation (AF) to sinus rhythm (SR)?

article thumbnail

Birth cohort effect in atrial fibrillation: a matter of detection?

Heart BMJ

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, affecting an estimated 43 million people globally. 1 Long-term AF management, including outpatient visits, hospitalisations and disabilities from stroke and heart failure (HF), adds substantial burden on healthcare resources and costs, accounting for 2.6%

article thumbnail

Atrial fibrillation and COVID-19: an analysis of the ambulatory database

Frontiers in Cardiovascular Medicine

Atrial fibrillation (AF) is the most common heart rhythm disorder in clinical practice. In this study, an electronic database of outpatients with AF, including patients with a history of COVID-19 infection was analyzed in order to assess the most significant risk factors for complications.

article thumbnail

QI-482886-005 IMPROVEMENT OF ANTICOAGULANTS PRESCRIPTION AND CLINICAL OUTCOMES AFTER IMPLANTATION OF AN AF ALERT SYSTEM IN THE OUTPATIENT DEPARTMENT

HeartRhythm

In previous randomized controlled trial, the alert system modestly enhanced the prescription of OAC among consecutive hospitalized patients with atrial fibrillation (AF).

article thumbnail

QI-482886-001 ENHANCING ADHERENCE TO GUIDELINE-DIRECTED USE OF ANTICOAGULANT THERAPY IN ATRIAL FIBRILLATION: A TRIAD OF QUALITY IMPROVEMENT INTERVENTIONS IN AN ACADEMIC OUTPATIENT SETTING

HeartRhythm

Anticoagulation for stroke prevention is often recommended for patients with nonvalvular atrial fibrillation (AF), yet for variable reasons many eligible patients do not receive guideline-concordant anticoagulation. Prior quality improvement (QI) initiatives to improve anticoagulation in AF have had mixed results.